Drug Profile
Triamcinolone acetonide injectable suspension - AbbVie
Alternative Names: TrivarisLatest Information Update: 05 Nov 2021
Price :
$50
*
At a glance
- Originator Allergan
- Developer AbbVie
- Class Analgesics; Anti-inflammatories; Antiallergics; Antiasthmatics; Antipsoriatics; Antirheumatics; Eye disorder therapies; Fluorinated steroids; Glucocorticoids; Pregnadienes; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Ocular inflammation
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 17 Jun 2008 Registered for Ocular inflammation in USA (Intravitreous)